Tongsheng was founded in 2003 and has been deeply engaged in the field of amino acids and pharmaceutical raw materials for 23 years. Headquartered in Deyang City, Sichuan Province, it is a pharmaceutical enterprise integrating the research and development, production and sales of pharmaceutical intermediates, active pharmaceutical ingredients, and key starting materials for small molecule drugs and peptide drugs. Establish an operation policy of "one headquarters and three bases", and provide a high-capacity, high-quality and high-efficiency service model. The production base has been established in strict accordance with the national GMP requirements and has obtained the drug production license. All of them have mature production technologies and standardized quality systems. Empower the commercial production of Tongsheng Group's products, with an annual output of over a thousand tons. After years of efforts, by establishing the most advanced R&D capabilities, Tongsheng has achieved significant success in providing customized synthesis services for the world's leading pharmaceutical companies, CDMO companies, and API enterprises. Tongsheng's products cover the screening, small-scale trials, medium-scale trials and commercial production services of key materials for new clinical drugs. It has currently empowered hypoglycemic drugs, antiviral drugs, anti-tumor drugs and immunosuppressants. Adhering to the business philosophy of "born together, thrive together, and win together", we constantly optimize the customer experience, continuously expand and enrich our product pipeline, and work hand in hand with our customers to strive for the cause of human health.
